Evidence map›Paper›PMID 41510603›Full record

ArticleLab on a chip2026

Affordable, cleanroom-free millifluidic production of targeted lipid nanocarriers

Callum D Hay, Suchaya M Mahutanattan, Colin P Pilkington, Miguel Paez-Perez, Kimberly A Kelly, Yuval Elani, Marina K Kuimova, Nicholas J Brooks, Michela Noseda, James W Hindley and 1 more

Abstract read
In one paragraph

Article in Lab on a chip, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Callum D HayDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.
Suchaya M MahutanattanDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.
Colin P PilkingtonDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.ORCID 0000-0002-3113-7611
Miguel Paez-PerezDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.ORCID 0000-0003-3933-8722
Kimberly A KellyDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, USA.
Yuval ElaniInstitute of Chemical Biology, Imperial College London, Molecular Sciences Research Hub, London, W12 0BZ, UK.ORCID 0000-0002-9603-2490
Marina K KuimovaDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.ORCID 0000-0003-2383-6014
Nicholas J BrooksDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.
Michela NosedaImperial Centre for Translation and Experimental Medicine, Imperial College London, Hammersmith Campus, London, SW7 2AZ, UK.
James W HindleyDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.ORCID 0000-0002-3392-4387
Oscar CesDepartment of Chemistry, Molecular Science Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK. j.hindley14@imperial.ac.uk.ORCID 0000-0002-6418-5644

Funding

BBSRC-funded 21ENGBIO BB/W012871/1BHF-funded grants RG/15/1/31165BHF-funded grants SP/19/1/34461British Heart Foundation EP/S023518/1
6 · The paper itself

Abstract

Lipid nanocarriers utilise the self-assembly of amphiphilic molecules to generate particle formulations capable of drug encapsulation and dynamic interactions with user-defined cell types, enabling applications within targeted therapeutic delivery. This offers increased bioavailability, stability, and reduced off-target effects, with the promise of application to numerous cell types and consequently, diseases. Here, we have developed a highly accessible, cleanroom-free method for the fabrication of poly(methyl methacrylate) millifluidic vertical flow focusing (VFF) devices

Indexed as

Drug CarriersLipidsMicrofluidic Analytical TechniquesNanoparticlesAnimalsCell LineCell SurvivalMyocytes, CardiacPolymethyl MethacrylateVitamin K 3Drug CarriersLipidsPolymethyl MethacrylateVitamin K 3

Identifiers

PMID41510603
PMCPMC12784244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.